Since KDM6A connects KMT2D and RB1 mutations we hypothesize that there is a biological pathway that unites the impact of these three mutated genes and is important for the biologic fitness of bladder cancer cells. The gene discussed is KDM6A; the disease is urinary bladder carcinoma.